journal article·2021-12

Crystal structure of ivermectin hemihydrate ethanolate, (C 48 H 74 O 14 )(H 2 O) 0.5 (C 2 H 5 OH) 0.82

James A. Kaduk, Allison Tanis, Alyssa Tovar, Nicholas C. Boaz, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 36· Issue 4
Publisher page

Abstract

The crystal structure of ivermectin hemihydrate ethanolate has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Ivermectin hemihydrate ethanolate crystallizes in space group C2 (#5) with a = 40.9374(10), b = 9.26951(6), c = 14.9488(2) Å, β = 73.047(1)°, V = 5426.12(8) Å 3 , and Z = 4. The structure consists of layers of ivermectin molecules parallel to the bc -plane. The water and ethanol molecules reside in small voids in the structure. The water molecule, the ethanol molecule, and hydroxyl groups act as donors in O–H⋯O hydrogen bonds. Several C–H⋯O hydrogen bonds were detected. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Pigment Synthesis and Properties · Crystallography and molecular interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Etudes sur la loi de Bravais
2. 10.1063/1.296926010.1063/1.2969260 ↗
3. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
4. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
5. 2019
6. 10.1002/qua.2465810.1002/qua.24658 ↗
7. 2013
8. 10.1007/BF0054909610.1007/BF00549096 ↗
9. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
10. 2016
11. 10.1107/S160057671901409210.1107/S1600576719014092 ↗
12. 10.1021/jo971176v10.1021/jo971176v ↗
13. Preformulation study of ivermectin raw material
14. 10.1017/S088571561400090610.1017/S0885715614000906 ↗
15. A new law of crystal morphology extending the law of Bravais
16. 10.1017/S088571561900081210.1017/S0885715619000812 ↗
17. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
18. Bravais · 1866
19. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
20. 10.1021/ci049780b10.1021/ci049780b ↗
21. Seppala, E. , Kolehmainen, E. , Osmialowski, B. , and Gawinecki, R. (2014). CSD Communication; Refcode BIFYOF.
22. MDI (2019). MDI JADE Pro Version 7.7 (Materials Data, Livermore, CA).
23. 10.1038/s41429-020-0336-z10.1038/s41429-020-0336-z ↗
24. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
25. 10.1063/1.46788210.1063/1.467882 ↗
26. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
27. Turner, M. J. , McKinnon, J. J. , Wolff, S. K. , Grimwood, D. J. , Spackman, P. R. , Jayatilaka, D. , and Spackman, M. A. (2017). CrystalExplorer17 (University of Western Australia). Available at: http://hirshfeldsurface.net.
28. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
29. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
30. Wavefunction, Inc. (2019). Spartan ‘18 Version 1.4.4, Wavefunction Inc., 18401 Von Karman Ave., Suite 370, Irvine, CA 92612.
31. Grobler, M. L. J. (2016). “Crystal polymorphism and pseudopolymorphism of ivermectin,” Master's Thesis, North-West University, Potchefstroom, South Africa.